Elotuzumab Directly Enhances NK Cell Cytotoxicity Against Myeloma via CS1 Ligation: Evidence for Augmented NK Cell Function Complementing ADCC

Cancer Immunology, Immunotherapy - Germany
doi 10.1007/s00262-013-1493-8

Related search